Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications

Colloids and Surfaces B: Biointerfaces

Volumn 140, Issue , 2016, Pages 505-513

  Massaro, M ^a   Amorati, R ^b   Cavallaro, G ^a   Guernelli, S ^b   Lazzara, G ^a   Milioto, S ^a   Noto, R ^a   Poma, P ^a   Riela, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Dipartimento di Chimica Giacomo Ciamician   (Italy)

Author keywords

Antioxidant properties; Antiproliferative activity; Curcumin; Halloysite nanotubes; Prodrug

Indexed keywords

ANTIOXIDANTS; CHEMICAL RESISTANCE; CONTROLLED DRUG DELIVERY; KAOLINITE; LIGHT SCATTERING; NANOTUBES; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRIC ANALYSIS; ULTRAVIOLET VISIBLE SPECTROSCOPY; YARN;

ANTI-PROLIFERATIVE ACTIVITIES; ANTIOXIDANT PROPERTIES; CURCUMIN; HALLOYSITE NANOTUBES; PRODRUGS;

GRAFTING (CHEMICAL);

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CURCUMIN; GLUTATHIONE; HALLOYSITE NANOTUBE; MERCAPTAMINE; NANOCARRIER; NANOTUBE; PRODRUG; SCHIFF BASE; UNCLASSIFIED DRUG; ALUMINUM SILICATE; ANTINEOPLASTIC AGENT; CLAY; DRUG CARRIER; SCAVENGER;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; PH; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; ULTRAVIOLET SPECTROSCOPY; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; OXIDATION REDUCTION REACTION; TUMOR CELL LINE; ULTRASTRUCTURE;

ALUMINUM SILICATES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; DRUG CARRIERS; FREE RADICAL SCAVENGERS; HUMANS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; NANOTUBES; OXIDATION-REDUCTION; PRODRUGS;

EID: 84955135014     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.01.025     Document Type: Article

References (68)

1. Y. Lvov, W. Wang, L. Zhang, R. Fakhrullin, Halloysite clay nanotubes for loading and sustained release of functional compounds, Adv. Mater. doi: . http://10.1002/adma.201502341.
2. Wang Q., Zhang J., Zheng Y., Wang A. Adsorption and release of ofloxacin from acid- and heat-treated halloysite. Colloids Surf. B 2014, 113:51-58.
3. Riela S., Massaro M., Colletti C.G., Bommarito A., Giordano C., Milioto S., Noto R., Poma P., Lazzara G. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. Int. J. Pharm. 2014, 475:613-623.
4. Vergaro V., Abdullayev E., Lvov Y.M., Zeitoun A., Cingolani R., Rinaldi R., Leporatti S. Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromolecules 2010, 11:820-826.
5. Lvov Y., Aerov A., Fakhrullin R. Clay nanotube encapsulation for functional biocomposites. Adv. Colloid Interface Sci. 2014, 207:189-198.
6. Dzamukova M.R., Naumenko E.A., Lvov Y.M., Fakhrullin R.F. Enzyme-activated intracellular drug delivery with tubule clay nanoformulation. Sci. Rep. 2015, 5:10560.
7. Abdullayev E., Lvov Y. Halloysite clay nanotubes for controlled release of protective agents. J. Nanosci. Nanotechnol. 2011, 11:10007-10026.
8. Yah W.O., Takahara A., Lvov Y.M. Selective modification of halloysite lumen with octadecylphosphonic acid: new inorganic tubular micelle. J. Am. Chem. Soc. 2012, 134:1853-1859.
9. Cavallaro G., Lazzara G., Milioto S., Parisi F., Sanzillo V. Modified halloysite nanotubes: nanoarchitectures for enhancing the capture of oils from vapor and liquid phases. ACS Appl. Mater. Interfaces 2014, 6:606-612.
10. Lvov Y., Abdullayev E. Functional polymer-clay nanotube composites with sustained release of chemical agents. Prog. Polym. Sci. 2013, 38:1690-1719.
11. Fakhrullina G.I., Akhatova F.S., Lvov Y.M., Fakhrullin R.F. Toxicity of halloysite clay nanotubes in vivo: a Caenorhabditis elegans study. Environ. Sci. Nano 2015, 2:54-59.
12. Viseras M.-T., Aguzzi C., Cerezo P., Cultrone G., Viseras C. Supramolecular structure of 5-aminosalycilic acid/halloysite composites. J. Microencapsul. 2009, 26:279-286.
13. Ghebaur A., Garea S.A., Iovu H. New polymer-halloysite hybrid materials-potential controlled drug release system. Int. J. Pharm. 2012, 436:568-573.
14. Levis S.R., Deasy P.B. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int. J. Pharm. 2003, 253:145-157.
15. Price B.P.G.R., Lvov Y. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. J. Microencapsul. 2001, 18:713-722.
16. Veerabadran N.G., Price R.R., Lvov Y.M. Clay nanotubes for encapsulation and sustained release of drugs. Nano 2007, 2:115-120.
17. Massaro M., Colletti C.G., Noto R., Riela S., Poma P., Guernelli S., Parisi F., Milioto S., Lazzara G. Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems. Int. J. Pharm. 2015, 478:476-485.
18. Cavallaro G., Lazzara G., Massaro M., Milioto S., Noto R., Parisi F., Riela S. Biocompatible poly(N-isopropylacrylamide)-halloysite nanotubes for thermoresponsive curcumin release. J. Phys. Chem. C 2015, 119:8944-8951.
19. Araújo C., Leon L. Biological activities of Curcuma longa L. Mem. Inst. Oswaldo Cruz 2001, 96:723-728.
20. Hsu C.H., Cheng A.L. Clinical studies with curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease 2007, 471-480. Springer, US. B. Aggarwal, Y.J. Surh, S. Shishodia (Eds.).
21. Unnikrishnan M.K., Rao M.N.A. Curcumin inhibits nitrogen dioxide induced oxidation of hemoglobin. Mol. Cell. Biochem. 1995, 146:35-37.
22. Anto R.J., Kuttan G., Babu K.V.D., Rajasekharan K.N., Kuttan R. Anti-tumour and free radical scavenging activity of synthetic curcuminoids. Int. J. Pharm. 1996, 131:1-7.
23. Ak T., Gülçin I. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 2008, 174:27-37.
24. Agnihotri N., Mishra P.C. Scavenging mechanism of curcumin toward the hydroxyl radical: a theoretical study of reactions producing ferulic acid and vanillin. J. Phys. Chem. A 2011, 115:14221-14232.
25. Borsari M., Ferrari E., Grandi R., Saladini M. Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability. Inorg. Chim. Acta 2002, 328:61-68.
26. Kant V., Gopal A., Pathak N.N., Kumar P., Tandan S.K., Kumar D. Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats. Int. Immunopharmacol. 2014, 20:322-330.
27. Choi H., Chun Y.-S., Kim S.-W., Kim M.-S., Park J.-W. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol. Pharmacol. 2006, 70:1664-1671.
28. Aggarwal S., Ichikawa H., Takada Y., Sandur S.K., Shishodia S., Aggarwal B.B. Curcumin (Diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol. Pharmacol. 2006, 69:195-206.
29. Lin Y.G., Kunnumakkara A.B., Nair A., Merritt W.M., Han L.Y., Armaiz-Pena G.N., Kamat A.A., Spannuth W.A., Gershenson D.M., Lutgendorf S.K., Aggarwal B.B., Sood A.K. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway. Clin. Cancer Res. 2007, 13:3423-3430.
30. Kurien B.T., Singh A., Matsumoto H., Scofield R.H. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol. 2007, 5:567-576.
31. Wang Y.-J., Pan M.-H., Cheng A.-L., Lin L.-I., Ho Y.-S., Hsieh C.-Y., Lin J.-K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
32. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
33. Amano C., Minematsu H., Fujita K., Iwashita S., Adachi M., Igarashi K., Hinuma S. Nanoparticles containing curcumin useful for suppressing macrophages in vivo in mice. PLoS One 2015, 10.
34. Yu S., Ding J., He C., Cao Y., Xu W., Chen X. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy. Adv. Healthcare Mater. 2014, 3:752-760.
35. Chow E.K.-H., Ho D. Cancer nanomedicine: from drug delivery to imaging. Sci. Transl. Med. 2013, 5(216). 216rv4-216rv4.
36. Wang Y., Shim M.S., Levinson N.S., Sung H.-W., Xia Y. Stimuli-responsive materials for controlled release of theranostic agents. Adv. Funct. Mater. 2014, 24:4206-4220.
37. Bonacchi S., Genovese D., Juris R., Montalti M., Prodi L., Rampazzo E., Zaccheroni N. Luminescent silica nanoparticles: extending the frontiers of brightness. Angew. Chem. Int. Ed. 2011, 50:4056-4066.
38. Montalti M., Prodi L., Rampazzo E., Zaccheroni N. Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine. Chem. Soc. Rev. 2014, 43:4243-4268.
39. Nicolas J., Mura S., Brambilla D., Mackiewicz N., Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 2013, 42:1147-1235.
40. MacEwan S.R., Callahan D.J., Chilkoti A. Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine 2010, 5:793-806.
41. Yin Q., Shen J., Zhang Z., Yu H., Li Y. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. Adv. Drug Deliv. Rev. 2013, 65:1699-1715.
42. Zhou Z., Ma X., Jin E., Tang J., Sui M., Shen Y., Van Kirk E.A., Murdoch W.J., Radosz M. Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery. Biomaterials 2013, 34:5722-5735.
43. van der Vlies A.J., Hasegawa U., Hubbell J.A. Reduction-sensitive tioguanine prodrug micelles. Mol. Pharm. 2012, 9:2812-2818.
44. Massaro M., Riela S., Cavallaro G., Gruttadauria M., Milioto S., Noto R., Lazzara G. Eco-friendly functionalization of natural halloysite clay nanotube with ionic liquids by microwave irradiation for Suzuki coupling reaction. J. Organomet. Chem. 2014, 749:410-415.
45. Ambrogio M.W., Pecorelli T.A., Patel K., Khashab N.M., Trabolsi A., Khatib H.A., Botros Y.Y., Zink J.I., Stoddart J.F. Snap-top nanocarriers. Org. Lett. 2010, 12:3304-3307.
46. Chandrasekar T., Pravin N., Raman N. Biosensitive metal chelates from curcumin analogues: DNA unwinding and anti-microbial evaluation. Inorg. Chem. Commun. 2014, 43:45-50.
47. The ability of a specific solvent to convert microwave energy into heat at a given frequency and temperature is determined by the so-called loss tangent (tan d), expressed as the quotient, tan d=e/e', where e is the dielectric loss, indicative of the efficiency with which electromagnetic radiation is converted into heat, and e' is the dielectric constant, describing the ability of molecules to be polarized by the electric field In general, solvents used for microwave synthesis can be classified as high (tan δ >0.5), medium (tan δ 0.1-0.5) and low microwave absorbing (tan δ <0.1).
48. Cavallaro G., Lazzara G., Milioto S. Dispersions of nanoclays of different shapes into aqueous and solid biopolymeric matrices extended physicochemical study. Langmuir 2011, 27:1158-1167.
49. Xu Z., Wang D., Xu S., Liu X., Zhang X., Zhang H. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Chem. Asian J. 2014, 9:199-205.
50. Sun M., Gao Y., Guo C., Cao F., Song Z., Xi Y., Yu A., Li A., Zhai G. Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle. J. Nanopart. Res. 2010, 12:3111-3122.
51. Bondi M., Azzolina A., Craparo E., Botto C., Amore E., Giammona G., Cervello M. Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells. J. Nanobiotechnol. 2014, 12:21.
52. Craparo E.F., Sardo C., Serio R., Zizzo M.G., Bondì M.L., Giammona G., Cavallaro G. Galactosylated polymeric carriers for liver targeting of sorafenib. Int. J. Pharm. 2014, 466:172-180.
53. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379:1245-1255.
54. Mu Q., Hondow N.S., Krzemiński Ł., Brown A.P., Jeuken L.J., Routledge M.N. Mechanism of cellular uptake of genotoxic silica nanoparticles. Part. Fibre Toxicol. 2012, 9:1-11.
55. Shang L., Nienhaus K., Nienhaus G. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 2014, 12:5.
56. Massaro M., Piana S., Colletti C.G., Noto R., Riela S., Baiamonte C., Giordano C., Pizzolanti G., Cavallaro G., Milioto S., Lazzara G. Multicavity halloysite-amphiphilic cyclodextrin hybrids for co-delivery of natural drugs into thyroid cancer cells. J. Mater. Chem. B 2015, 3:4074-4081.
57. Malik P., Mukherjee T.K. Structure-function Elucidation of Antioxidative and Prooxidative Activities of the Polyphenolic Compound Curcumin 2014, Hindawi Publishing Corporation Chinese Journal of Biology.
58. Priyadarsini K.I., Maity D.K., Naik G.H., Kumar M.S., Unnikrishnan M.K., Satav J.G., Mohan H. Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med. 2003, 35:475-484.
59. Parvathy K.S., Negi P.S., Srinivas P. Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside. Food Chem. 2009, 115:265-271.
60. Wilken R., Veena M., Wang M., Srivatsan E. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 2011, 10:12.
61. Amorati R., Valgimigli L. Advantages and limitations of common testing methods for antioxidants. Free Radic. Res. 2015, 49:633-649.
62. Viglianisi C., Di Pilla V., Menichetti S., Rotello V.M., Candiani G., Malloggi C., Amorati R. Linking an α-tocopherol derivative to cobalt(0) nanomagnets: magnetically responsive antioxidants with superior radical trapping activity and reduced cytotoxicity. Chem. Eur. J. 2014, 20:6857-6860.
63. Burton G.W., Ingold K.U. Autoxidation of biological molecules 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc. 1981, 103:6472-6477.
64. Johansson H., Shanks D., Engman L., Amorati R., Pedulli G.F., Valgimigli L. Long-lasting antioxidant protection: a regenerable BHA analogue. J. Organomet. Chem. 2010, 75:7535-7541.
65. Mishra K., Ojha H., Chaudhury N.K. Estimation of antiradical properties of antioxidants using DPPH assay: a critical review and results. Food Chem. 2012, 130:1036-1043.
66. Amorati R., Menichetti S., Viglianisi C., Foti M.C. Proton-electron transfer pathways in the reactions of peroxyl and dpph[radical dot] radicals with hydrogen-bonded phenols. Chem. Commun. 2012, 48:11904-11906.
67. Amorati R., Valgimigli L. Modulation of the antioxidant activity of phenols by non-covalent interactions. Org. Biomol. Chem. 2012, 10:4147-4158.
68. 2 nanoparticles covalently functionalized with gallic acid. ACS Appl. Mater. Interfaces 2012, 4:6609-6617.